SCHEMBL6174080

SCHEMBL6174080

O=C(Nc1ccccc1)Oc1cc2cc([N+](=O)[O-])ccc2n1CCc1ccccc1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 5/20 0.45
MEN1 O00255 4/20 0.45
KMT2A Q03164 4/20 0.45
ALDH1A1 P00352 4/20 0.45
ECE1 P42892 1/20 0.45
NPC1 O15118 2/20 0.43
PKM P14618 1/20 0.43
RAB9A P51151 1/20 0.43
SMN1; SMN2 Q16637 3/20 0.43
THRB P10828 1/20 0.43
HPGD P15428 1/20 0.43
ALOX12 P18054 1/20 0.43
LMNA P02545 1/20 0.43
MAOA P21397 1/20 0.43
MAOB P27338 1/20 0.43
HTT P42858 1/20 0.43
GNRHR P30968 1/20 0.42
EGFR P00533 1/20 0.42
SRC P12931 1/20 0.42
RECQL P46063 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6175680 0.89 EGFR (0.45) MAPTMEN1KMT2AALDH1A1PKM
SCHEMBL6018659 0.83 ECE1 (0.63) MAPTMEN1KMT2AALDH1A1ECE1
SCHEMBL6175264 0.83 ECE1 (0.46) MAPTMEN1KMT2AECE1NPC1
SCHEMBL6175232 0.82 ECE1 (0.47) MAPTMEN1KMT2AALDH1A1ECE1
SCHEMBL6176218 0.82 ECE1 (0.47) MAPTMEN1KMT2AALDH1A1ECE1
SCHEMBL8132926 0.78 ALDH1A1 (0.45) MAPTMEN1KMT2AALDH1A1NPC1
SCHEMBL27361127 0.75 PKM (0.53) MAPTMEN1KMT2APKMHPGD
SCHEMBL8131716 0.74 MAPT (0.50) MAPTMEN1KMT2AALDH1A1RAB9A
SCHEMBL6606652 0.74 MEN1 (0.45) MAPTMEN1KMT2AALDH1A1ECE1
SCHEMBL6173528 0.74 ECE1 (0.44) MEN1KMT2AALDH1A1ECE1MAOB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1432415-B1 SUBSTITUTED 2,5-DIAMIDOINDOLES AS ECE INHIBITORS FOR THE TREATMENT OF CARDIOVASCULAR DISEASES BAYER HEALTHCARE AG (DE) 2005-12-28 EP disclosed
EP-1432415-A1 SUBSTITUTED 2,5-DIAMIDOINDOLES AS ECE INHIBITORS FOR THE TREATMENT OF CARDIOVASCULAR DISEASES Bayer HealthCare AG (DE) 2004-06-30 EP disclosed
WO-2003028719-A1 SUBSTITUTED 2,5-DIAMIDOINDOLES AS ECE INHIBITORS FOR THE TREATMENT OF CARDIOVASCULAR DISEASES BAYER HEALTHCARE AG (DE) 2003-04-10 WO disclosed